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Objective. A prospective study to clarify the impact of forward bilateral sagittal split osteotomy (BSSO) on
temporomandibular dysfunction (TMD).
Study Design. We examined and interviewed patients with BSSO before and at 1 year after surgery to evaluate the changes in
TMD symptoms. A well-known TMD index, which incorporated two complementary subindicesdthe objective functional
Helkimo dysfunction index (Di) and the subjective symptomatic anamnestic index (Ai)dwas used. Patients with a forward
movement of the mandible and osteosynthesis with titanic miniplates were included.
Results. Forty patients (26 females and 14 males, mean age of study population 36.9 years) retrognathia completed the study.
There was no change in TMD symptoms in 24 patients (60%), as measured by the Di, and 26 (65%), as measured by the Ai.
Twelve patients improved (30%), according to the Di scores and 10 (25%) according to the Ai scores. Four patients had more
TMD symptoms at follow-up (10%), as measured by both Di and Ai.
Conclusions. Surgery for orthognathia is a predictable treatment for improving aesthetics and occlusion but less predictable
for alleviating TMD symptoms in patients with retrognathia. TMD symptoms should therefore be treated independently. (Oral
Surg Oral Med Oral Pathol Oral Radiol 2016;121:595-601)One of the reasons for retrognathic patients seeking
treatment1-3 or for dentists referring patients for
orthognathic surgery is temporomandibular dysfunction
(TMD). Bilateral sagittal split osteotomy4 (BSSO) is the
standard treatment for the correction of a congenitally
small and retrognathic lower jaw. Whether
orthognathic surgery is itself a predictable treatment
for patients whose primary reason for referral is TMD
is a question that needs to be answered.
The question of predictability of TMD in patients
with orthognathia has been one of the controversies in
oral and maxillofacial surgery, and it is well known that
TMD symptoms and clinical findings fluctuate over
time.5-7 The symptoms can originate from the joint or
from the surrounding musculoskeletal structures. Pa-
tients often experience pain, joint sounds, muscle
tenderness, or deviations or restriction of movement of
the mandible.
There is insufficient evidence in the existing pub-
lished literature, with just a few prospective studies that
cover orthognathic surgery and TMD.3,8-12 Most
studies report favorable corrective results for TMD,
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BSSO patients (64 mandibular advancements and 18
mandibular setbacks) reported that the TMD symptoms
were reduced or remained unchanged for 88% of
patients but worsened for 12%.3
In many of the studies, the Helkimo anamnestic in-
dex (Ai), the dysfunction index (Di), or slightly modi-
fied versions of these were used to evaluate the TMD
symptoms.3,9,11 Abrahamsson et al.12 published a study
in 2013 on patients with orthognathia, which used the
Research Diagnostic Criteria for Temporomandibular
Disorders (RDC/TMD), published in 1992,13 to
evaluate TMD. All previous studies had included
different surgical procedures or diagnoses of
malocclusions in their final analyses.
There is no previously published prospective study
on improving TMD symptoms for patients with
mandibular retrognathia undergoing BSSO. We there-
fore asked the specific question: What is the impact of
forward BSSO on TMD symptoms in patients with
retrognathia? We then conducted a prospective study
with class II patients who were to undergo forward
BSSO, with a follow-up time of 1 year, and scored theStatement of Clinical Relevance
Our study has shown that the forward movement of a
retrognathic mandible with the aid of bilateral
sagittal split osteotomy is an unpredictable treatment
for temporomandibular dysfunction, although pa-
tients often are referred for surgery for these reasons.
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index comprising the two aforementioned indicesd
Helkimo Ai and Di.
PATIENTS AND METHODS
We designed and carried out a prospective study that
included adult patients with Class II mandibular retro-
gnathia. All patients were at least 18 years of age and
were to undergo advancement of the mandible with the
aid of standard BSSO at the Helsinki University Hos-
pital’s Department of Oral and Maxillofacial Diseases,
during a period of 18 months. Patients who underwent
any other preplanned surgical procedures of the
mandible or maxilla during the first postoperative year
were excluded. Patients with any other malocclusions
or facial syndromes were also excluded, as were pa-
tients who had any other surgical procedures in the
maxillomandibular region, either before BSSO or dur-
ing the follow-up, except for patients with surgical
complications after BSSO.
All patients underwent preoperative and post-
operative orthodontics with fixed orthodontic appli-
ances in both arches to achieve the optimal occlusion.
All patients were operated on by an experienced senior
surgeon and by a surgeon-in-training. They usually
operated on one side each. Fixation using titanium
miniplates and monocortical screws was performed in
all patients. One horizontal titanium miniplate was
placed on each side of the mandible. No other fixation
was used, and the patients had no postoperative inter-
maxillary fixation. All patients had light guiding elas-
tics and a surgical splint for 4 weeks after the operation.
A follow-up time of 1 year was required for the patients
to be included in the final analysis.
The Di and the Ai, both of which were published by
Helkimo in 1974,14 were used to register preoperative
and 1-year postoperative TMD symptoms. Originally,
the TMD index consisted of three different subindices,
namely, the clinical dysfunction index (Di), the anam-
nestic dysfunction index (Ai), and the index for the
occlusal state (Oi). The first two, the Di and the Ai,
have since been used in epidemiologic and comparative
studies. The Di is based on objective TMD findings
during a clinical examination, whereas the Ai is based
on the patient’s subjective TMD symptoms and
complaints.
The Di is a clinical evaluation of the functional state
of the masticatory system, based on the five groups of
symptoms (impaired range of movement of the
mandible, impaired function of the TMD, pain on
movement of the mandible, pain in the temporoman-
dibular joint (TMJ), pain in the masticatory muscles).
Every symptom is judged on a three-grade scale of
severity: no symptoms awarded 0 points, mild symp-
toms 1, and severe symptoms 5. In our study, the scoresfor the five symptoms were added together. The
severity of TMD was scored as follows: clinically
symptom-free Di 0 (0 points), mild dysfunction Di I
(1e4 points), moderate dysfunction Di II (5e9 points),
and severe dysfunction Di III (10e25 points).
The Ai is based on data obtained by interviewing the
patient and is scored on the basis of the TMD symp-
toms reported by the patient. The patients in our study
were divided into three groups (IeIII) according to the
severity of symptoms reported: patients with no sub-
jective symptoms (Ai 0), patients with mild symptoms
of dysfunction (Ai I), and patients with severe symp-
toms (Ai II). The patients with mild symptoms had one
or more of the following symptoms: TMJ sounds,
feeling of fatigue of the jaws, and feeling of stiffness of
the lower jaw; however, none of the symptoms was
described as severe. The patients with severe symptoms
(Ai II) reported restrictions in mouth opening, locking,
luxation, pain on movement of the mandible, and pain
in the TMJ or the masticatory muscles. Facial pain
other than pain related to TMD was not included in the
index.
TMDs include a wide variety of symptoms of the
temporomandibular region, which can be related either
to the joints or to the surrounding muscular structures.
We used deviations, sounds, locking, and luxation as
indicators for joint-related symptoms and the number of
muscles tender to palpation as an indicator for muscle-
related problems.
All enrolled patients were interviewed and examined
according to a standard protocol before and 1 year after
the operation by one of the authors (MK). The reason
for referral for orthognathic surgery was recorded. We
also asked the patients about possible previous TMD
and occlusal splints they had. The Helkimo Ai and the
Di were recorded.
The study was approved by the Ethics Committee of
the Department of Surgery and by the Internal Review
Board of the Division of Musculoskeletal Surgery,
Helsinki University Central Hospital, Finland. All
participating patients signed a written informed consent
form. The study followed the principles of the Decla-
ration of Helsinki.
RESULTS
A total of 42 consecutive patients with retrognathia met
the inclusion criteria, and all of the patients consented
to participate in the study. Two patients did not appear
at the 1-year follow-up, thus their data were excluded,
which left the data of the 40 patients who completed the
study for the present analysis. Twenty-six patients
(65%) were female. The mean age of the study popu-
lation was 36.9 years (range 22.2e59.4 years). The
patients were generally healthy. Three patients were
taking medication for hypothyreosis, one patient had





One year after operation
%No. of patients No. of patients
Mobility index 0 (0 points) 23 57.5 24 60
1 (1e4 points) 14 35 15 37.5
5 (5e20 points) 3 7.5 1 2.5
Temporomandibular function No sounds 28 70 26 65
Sounds/deviation >2 mm 12 30 14 35
Locking or luxation 0 0 0 0
Muscular pain on palpation No pain 18 45 23 57.5
1e3 sites 11 27.5 12 30
4 or more sites 11 27.5 5 12.5
Joint pain on palpation No 25 62.5 37 92.5
Lateral aspect pain 12 30 3 7.5
Distal aspect pain 3 7.5 0 0
Pain on mandibular movement No 37 92.5 37 92.5
One movement 3 7.5 2 5
Less than one movement 0 0 1 2.5
Clinical dysfunction index (Di)
Clinically symptom free Di 0 11 27.5 10 25
Mild symptoms Di I 14 35 24 60
Moderate symptoms Di II 13 32.5 5 12.5
Severe symptoms Di III 2 5 1 2.5
Table II. Change in Helkimo dysfunction index (Di)
for 40 individual patients during follow-up
Di (preoperative)- Di (1 year










D0, clinically symptom free; DI, mild symptoms; DII, moderate
symptoms; DIII, severe symptoms.
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smokers. All 40 patients had mandibular retrognathia,
33 (82.5%) patients had a deep bite, and 4 (10%) pa-
tients had a slight mandibular asymmetry. Four patients
were seen to have a slight flattening of the condyle in
the preoperative radiographic orthopantomogram, and
the condyles appeared normal for the other 36 patients.
Seventeen patients (42.5%) had a notation of TMD
as one of the reasons for seeking treatment at the first
appointment, and 12 patients (30%) had a history of an
occlusal splint for TMD.
The mean operation time was 123 minutes (range
75e165 minutes). Data were missing for one patient.
The mean forward movement was 6.3 mm (range
4.5e10 mm). The mandibles of four patients were
simultaneously rotated slightly. One patient was reop-
erated on 2 weeks after the first BSSO, and a refixation
was performed because of an unacceptable occlusion.
The preoperative and 1-year postoperative Di results
are presented in Table I. At the beginning of treatment,
11 patients had no (27.5%) TMD, 14 patients had mild
(35%) TMD, and 13 patients had (32.5%) moderate
TMD. Two patients (5%) had severe symptoms. Two
patients were lost to follow-up and were not included
in these numbers. Both had mild symptoms (Di I) at the
beginning of treatment. The changes in Di for indi-
vidual patients are shown in Table II. Four patients
developed functional or symptomatic impairments:
Three symptom-free patients developed mild symp-
toms, and in one patient, the symptoms changed from
mild to severe. Twelve patients improved their Di orTMD scores: Two patients with mild symptoms became
symptom free, and eight patients with moderate
symptoms and two patients with initially severe
symptoms had mild symptoms at follow-up. Sixteen
patients showed no improvement; of these, 11 patients
had mild symptoms, and five patients had moderate
symptoms at follow-up. Eight patients were symptom
free during the whole study. A total of 10 patients were
symptom free at follow-up.
Twenty patients (50%) had severe symptoms at the
beginning of treatment, as evaluated by the Ai
(Table III), and this number decreased to 12 (30%) at
the end of the follow-up period. Fifteen (37.5%) pa-
tients were symptom free at the beginning of treatment,
and 22 (55%) of the same patients were symptom free
Table III. Helkimo anamnestic index (Ai) in 40 pa-







15 37.5 22 55
Ai I Mild symptoms 5 12.5 6 15
Ai II Severe symptoms 20 50 12 30
Table IV. Change in Helkimo anamnestic index (Ai)
for individual patients during follow-up
Ai (preoperative)- Ai (1 year
postoperative) No. of patients %
Ai 0-Ai 0 12 30
Ai 0-Ai II 3 7.5
Ai I-Ai I 4 10
Ai I-Ai II 1 2.5
Ai II-Ai 0 5 12.5
Ai II-Ai I 5 12.5
Ai II-Ai II 10 25
40 100
Ai 0, no symptoms; Ai I, mild symptoms; Ai II, severe symptoms.
Table V. Change in temporomandibular dysfunction
symptom scores for Ai and Di at 1 year follow-up after
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individual patients are shown in Table IV. The
condition of four patients worsened: Three previously
symptom-free patients developed severe symptoms,
and one with initially mild symptoms ended up with
severe symptoms. A total of 10 patients improved; of
these, five patients with severe symptoms had mild
symptoms, and an additional five patients were symp-
tom free at follow-up. Symptoms were unchanged in 10
patients who had severe symptoms and in four patients
with mild symptoms. Twelve patients were symptom
free during the whole study. A total of 17 patients were
symptom free at the end of the study.
The changes in the Di and the Ai scores during the
follow-up period are shown in Table V. The severity of
TMD did not change in most patients during the follow-
up period. Ten patients (25%) had improved Ai scores,
and 12 (30%) patients had improved Di scores. The
TMD worsened in four (10%) patients, according to
both indices.
Table VI shows the changes in joint- and muscle-
related TMD symptoms. Sixteen patients improved or
developed impairments during follow-up, as measured
by the Di. In seven of the 12 patients who improved,
fewer muscles were tender to palpation, whereas the
situation remained unchanged for five patients. In one
of the four patients who worsened, an increasing
number of masticatory muscles were tender to palpa-
tion, whereas in the other three, the condition of the
masticatory muscles remained unchanged. Only two of
the 12 patients who showed improvement had joint-
related symptoms initially; the situation for joint-
related symptoms was unchanged in nine patients,
and one patient had more joint-related symptoms. Three
of the four patients whose symptoms worsened had
more joint-related symptoms, and in one, the situation
was unchanged.DISCUSSION
The main aim of this study was to clarify the impact of
BSSO on patients with retrognathia and TMD. A total
of 42 consecutive patients met the inclusion criteria,
and all of them agreed to participate in the study. Forty
patients completed the 1-year follow-up.BSSO is probably the most frequently used proce-
dure in the correction of malocclusions. The treatment
is lengthy and costly and can have complications.
Our data show that one of the main reasons for referrals
for BSSO was TMD, and 42.5% of the study patients
had a notation of TMD at the beginning of treatment.
The reason for seeking orthognathic treatment reported
in a previous Finnish study3 was regular headache and
facial pain (43%), TMD problems (30%), chewing
difficulties (23%), and dissatisfaction with facial and
dental appearance (11%). There are big cultural
differences among countries, and in many parts of the
world, aesthetics is the main reason for undergoing
orthognathic surgery.15 Our study found that 24
(60%) patients as measured by the Di and 26 patients
(65%) as measured by the Ai had no change in their
overall TMD scoring. Twelve patients (30%),
according to the Di and 10 patients (25%) according
to the Ai improved. The TMD condition of four
patients (10%) worsened regardless of the index used
for the evaluation (see Table V).
Most of the existing published reports are divergent
in study design and results. A major problem is the lack
Table VI. Change in joint and muscle TMD symptoms











Di improved Di impaired Di improved Di impaired
Improved 7 0 2 0
Unchanged 5 3 9 1
Impaired 0 1 1 3
Total 12 4 12 4
TMD, temporomandibular dysfunction; Di, Helkimo dysfunction
index.
Joint dysfunction indicates deviation, sound, locking, and luxation.
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research purposes, which would make the studies
directly comparable and reflect our current knowledge
in this field. We chose the complementary Helkimo Di
and Ai in combination as the TMD index,14 which was
originally published in 1974, because the TMD index
gives us the ability to compare our results with those
of earlier studies.3,9-11,16-18 There are critics of this in-
dex, and consequently there has been an effort to create
a new and updated index. The main limitations of the
index that we used in the present study are that it does
not differentiate between muscle-related and joint-
related pathologies, and symptoms that are nowadays
considered harmless, such as joint sounds,19 are
included in the index. Panula9 modified the index
slightly to be able to categorize patients with muscle,
joint, and mixed TMD symptoms, but we chose not
to do this because modifying the index even slightly
would invalidate any comparison between the data
from our patients with those of earlier studies.
One of the main problems with TMD studies is that
different pathologies, such as joint and musculoskeletal
pathologies, are all regarded as just one combined TMD
entity when they could and should be regarded as
discrete components. Therefore, we reported the change
in muscle-related and joint-related symptoms in
Table VI as separate endpoints in an attempt to
differentiate between these pathologies. The results
indicate that the great majority of the improvements
in the Di score were related to alleviation of muscle-
related symptoms. In the four patients who were
impaired, three patients had an increase in joint-related
symptoms. However, no far-reaching conclusions can
be drawn from the data of this study.
Another shortcoming is that the Helkimo indices do
not consider burden of the TMD condition on the pa-
tient on day-to-day basis. Consequently, the “Research
Diagnostic Criteria for Temporomandibular Disorders”
(RDC/TMD) was published in 1992.13,20 This index
has been revised to accommodate new research findings
that emerged during the years since its inception.21 Onerequirement is that a symptoms index used for research
should be in use for an extended period to allow
researchers to conduct directly comparable studies of
good quality. We found only a few comparable
studies12,22 on patients with orthognathia actually
matching the RDC/TMD.
Previous studies have described highly varying rates
of TMD. Our study’s Ai scores revealed that 65% of the
patients had no change in TMD symptoms, a further
25% of the patients improved, and the remaining 10%
had more symptoms 1 year after surgery. The change in
symptoms in an individual patient is still unpredictable.
Abrahamsson et al.12 reported in 2013 that 59.8% of the
patients had no change in their subjective TMD scores
after orthognathic surgery, according to the RDC/TMD
index. Those authors also reported that 85.4% of the
patients with moderate to severe symptoms at the
beginning of the treatment had no or slight symptoms
at follow-up. Four patients with no or slight symp-
toms at the beginning of treatment had moderate or
severe symptoms (10%) at the end of treatment. Pah-
kala and Kellokoski3 found that a significant proportion
of the patients benefited from the treatment, even when
12% of their patients with TMD worsened after BSSO.
A study conducted in 2002 by Dervis and Tuncer10
found that 10% of the patients developed new TMD
symptoms, which is in line with the findings of our
present study.
It is well known that TMD symptoms vary widely
over time, and therefore Abrahamsson et al.12 also
compared the results in the orthognathia group with
a control group consisting of patients referred for
normal dental treatment and occlusion, with no need
for orthodontics or orthognathic surgery.
Abrahamsson et al. found that 78.9% had no change
in symptoms, 60% of the patients with moderate to
severe symptoms improved, and 15.5% of the
patients with no or slight symptoms at the beginning
of the follow-up period had moderate to severe
symptoms at the end of the follow-up period. This
indicates that there was actually only a very small
difference between the patients undergoing BSSO and
the natural course of TMD in the control group.
Onizawa et al.8 came to the same conclusion in 1995
in their prospective study on 30 patients with
orthognathia and 30 healthy volunteers, and they
suggested that alterations of TMD after orthognathic
surgery do not always result from the actual surgical
correction of the malocclusion. We also agree with
this conclusion. There are no randomized, double-
blinded studies that have investigated TMD in pa-
tients with orthognathia. This might partly be
explained by the fact that it would be unethical to
postpone surgery for some patients with a severe
malocclusion, just for research purposes.
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utmost importance in BSSO patients. There has been
discussion about the different types of osteosynthesis
and their impact on TMD. We used titanium miniplates
and monocortical screws. Their fixation was semi-rigid,
which allows small adaptive changes to occlusion and
the condyles during function. Screw fixation is rigid and
unforgiving, and there is a risk for condylar torque, at
least in the hands of an inexperienced surgeon. There is
scant evidence in the literature on this topic. Yamashita
et al.18 showed that patients with a mandibular setback
and mini-plate fixation had significantly less severe
TMD symptoms compared with patients who had un-
dergone fixation with bicortical screws immediately after
the operation and during a follow-up period of 5 years.
They concluded that patients with plate fixation tended
to recover faster and had fewer symptoms of TMD.
CONCLUSIONS
Orthognathic treatment is lengthy and costly and
can have complications. Its efficacy for improving
TDM symptoms is still controversial. The outcome
with regard to the alleviation of TMD symptoms is still
unpredictable, and in the light of our current
knowledge, there is no sure way to predict the final
result of TMD in an individual patient. Patients and
referring colleagues should get appropriate information
about this lack of certainty, to reduce unrealistic ex-
pectations and thereby circumvent patient dissatisfac-
tion after treatment. We agree with the conclusion of
Nadershah and Mehra23 that occlusion and TMD
should be treated as two separate entities. Most
patients are highly satisfied with the treatment, and
the improvement of occlusion and facial aesthetics is
unquestionable.
There is an urgent need for more studies that use a
well-known TMD index with a well-defined follow-up
time and a robust study design. TMD symptoms in
individual patients fluctuate over time, and thus studies
with multiple measuring points, better differentiation
among TMD pathologies, and a longer follow-up time
would improve our current understanding of TMD.
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